Overview Financials News + Filings Key Docs Ownership Insiders
|
ALPHA HEALTHCARE ACQUISITION CORP III
|
|
Income Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Jun-30-21 |
| 10-Q | S-1 | 10-Q | S-1 | 10-Q |
Revenues | 0.0 | -0.3 | 0.0 | 0.3 | 0.0 |
Revenue growth | | -196.3% | | | |
Cost of goods sold | 0.0 | -2.5 | 0.0 | 0.3 | 0.0 |
Gross profit | 0.0 | 2.2 | 0.0 | 0.0 | 0.0 |
Gross margin | | -684.3% | | 0.0% | |
Selling, general and administrative [+] | 1.2 | 0.5 | 0.3 | 0.5 | 0.0 |
General and administrative | 1.2 | 0.5 | 0.3 | 0.5 | 0.0 |
Research and development | | 0.7 | | 0.5 | |
Other operating expenses | | 2.2 | | | |
EBITDA [+] | | -1.3 | | -0.9 | |
EBITDA growth | 306.3% | 34.9% | 4391.4% | | |
EBITDA margin | | 384.8% | | -274.8% | |
Depreciation | | 0.0 | | 0.0 | |
EBITA | -1.2 | -1.3 | -0.3 | -0.9 | 0.0 |
EBITA margin | | 391.8% | | -281.4% | |
Amortization of intangibles | | 0.0 | | 0.0 | |
EBIT [+] | -1.2 | -1.3 | -0.3 | -1.0 | 0.0 |
EBIT growth | 306.3% | 34.1% | 4391.4% | | |
EBIT margin | | 392.2% | | -281.7% | |
Interest expense | | 0.3 | | 0.2 | |
Interest expense | | 0.3 | | 0.2 | |
Other income (expense), net [+] | 1.9 | -0.3 | 0.2 | -0.3 | |
Other non-operating income | | 0.0 | | 0.0 | |
Pre-tax income | 0.7 | -1.8 | -0.1 | -1.5 | 0.0 |
Income taxes | 0.4 | 0.0 | 0.3 | 0.0 | 0.0 |
Tax rate | 55.0% | 0.0% | | 0.0% | 0.0% |
Net income | 0.3 | -2.1 | -0.3 | -1.5 | 0.0 |
Net margin | | 658.3% | | -454.9% | |
|
Basic EPS [+] | $0.02 | ($0.12) | ($0.02) | ($0.04) | $0.00 |
Growth | -190.1% | 205.4% | 925.6% | | |
Diluted EPS [+] | $0.02 | ($0.12) | ($0.02) | ($0.04) | $0.00 |
Growth | -190.1% | 205.4% | 925.6% | | |
|
Shares outstanding (basic) [+] | 20.2 | 18.3 | 19.9 | 40.1 | 3.8 |
Growth | 1.5% | -54.4% | 431.5% | | |
Shares outstanding (diluted) [+] | 20.2 | 18.3 | 19.9 | 40.1 | 3.8 |
Growth | 1.5% | -54.4% | 431.5% | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|